With the discovery that somatic mutations activating the PI3K/AKT/mTOR pathway are central to various vascular malformations, and the continuous advancements in genomic sequencing technologies, our understanding of the pathophysiological mechanisms underlying these conditions has deepened substantially. This evidence concerns the gene AKT1 and vascular malformation.